Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Glycerophospholipid metabolism (mmu00564)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
A530057A
03Rik
KLA  ATP  ATP+KLA
 NM_001081089 RIKEN cDNA A530057A03 gene (A530057A03Rik), mRNA [NM_001081089] KLA 1.06 1.10 1.05 1.03 1.12 1.14 1.27
ATP 1.04 1.11 1.07 1.01 .97 .99 1.06
KLA/ATP 1.10 1.19 1.14 .96 1.11 .91 1.09
AK165218
KLA  ATP  ATP+KLA
 AK165218 6 days neonate spleen cDNA, RIKEN full-length enriched library, clone:F420008K05 product:lipin 2, full insert sequence. [AK165218] KLA .96 .94 .83 1.03 1.08 .97 1.07
ATP 1.20 1.84 1.52 2.12 1.12 1.23 1.14
KLA/ATP .97 1.03 1.17 1.13 .98 1.07 1.21
Ache
KLA  ATP  ATP+KLA
 NM_009599 acetylcholinesterase (Ache), mRNA [NM_009599] KLA 1.01 1.02 1.03 1.07 1.03 1.05 1.05
ATP .96 1.02 1.03 1.02 1.10 1.04 1.08
KLA/ATP 1.06 .98 .97 1.04 1.04 1.13 1.12
Agpat1
KLA  ATP  ATP+KLA
 NM_018862 1-acylglycerol-3-phosphate O-acyltransferase 1 (lysophosphatidic acid acyltransferase, alpha) (Agpat1), mRNA [NM_018862] KLA 1.24 1.27 1.16 1.37 1.37 1.51 1.65
ATP .99 1.09 1.19 1.29 1.20 1.03 1.27
KLA/ATP 1.27 1.33 1.37 1.49 1.28 1.17 1.55
Agpat2
KLA  ATP  ATP+KLA
 NM_026212 1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta) (Agpat2), mRNA [NM_026212] KLA .88 .86 1.05 1.00 1.28 1.13 1.05
ATP 1.06 1.15 .95 1.09 .97 1.22 1.04
KLA/ATP .96 .94 .73 .87 .78 .97 .63
Agpat3
KLA  ATP  ATP+KLA
 NM_053014 1-acylglycerol-3-phosphate O-acyltransferase 3 (Agpat3), mRNA [NM_053014] KLA 1.13 1.10 1.05 1.19 1.28 1.33 1.53
ATP .95 .95 .89 .84 .79 .82 1.41
KLA/ATP .95 1.03 1.08 .94 .77 .75 1.42
Agpat4
KLA  ATP  ATP+KLA
 NM_026644 1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta) (Agpat4), mRNA [NM_026644] KLA 1.37 1.26 1.06 1.10 .98 1.29 1.77
ATP 1.05 .95 1.02 1.26 1.86 3.88 2.42
KLA/ATP 1.38 1.32 1.44 1.22 1.29 2.06 5.07
Agpat6
KLA  ATP  ATP+KLA
 NM_018743 1-acylglycerol-3-phosphate O-acyltransferase 6 (lysophosphatidic acid acyltransferase, zeta) (Agpat6), mRNA [NM_018743] KLA 1.14 1.08 1.21 1.15 1.17 1.25 1.50
ATP 1.05 1.02 .91 .91 1.11 1.42 1.26
KLA/ATP 1.16 1.17 .96 .87 1.00 1.40 1.35
Agpat9
KLA  ATP  ATP+KLA
 NM_172715 1-acylglycerol-3-phosphate O-acyltransferase 9 (Agpat9), transcript variant 1, mRNA [NM_172715] KLA .69 .70 .67 .64 .61 .61 .79
ATP .89 .77 .69 .57 2.26 2.30 1.90
KLA/ATP .67 .66 .68 .56 1.39 1.82 1.98
Cdipt
KLA  ATP  ATP+KLA
 NM_026638 CDP-diacylglycerol--inositol 3-phosphatidyltransferase (phosphatidylinositol synthase) (Cdipt), mRNA [NM_026638] KLA .75 .74 .71 .67 .79 .87 1.15
ATP 1.07 1.03 .76 .81 .75 .77 1.18
KLA/ATP .82 .72 .51 .53 .51 .72 1.22
Cds1
KLA  ATP  ATP+KLA
 NM_173370 CDP-diacylglycerol synthase 1 (Cds1), mRNA [NM_173370] KLA 2.81 2.96 3.63 3.43 3.28 1.96 .97
ATP 1.08 1.05 .86 .90 .78 .83 1.17
KLA/ATP 2.84 2.92 2.34 2.04 1.61 1.01 .98
Cds2
KLA  ATP  ATP+KLA
 NM_138651 CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2 (Cds2), mRNA [NM_138651] KLA 1.05 1.06 1.06 1.17 1.32 1.73 2.21
ATP .97 .93 .91 .77 .97 1.88 3.79
KLA/ATP 1.09 1.12 1.07 .94 1.16 1.49 4.77
Cept1
KLA  ATP  ATP+KLA
 NM_133869 choline/ethanolaminephosphotransferase 1 (Cept1), mRNA [NM_133869] KLA 3.40 3.07 3.72 5.13 5.83 5.57 2.91
ATP 1.09 1.05 1.09 .81 1.14 2.16 1.37
KLA/ATP 3.35 3.19 4.07 2.89 3.10 3.27 4.09
Chat
KLA  ATP  ATP+KLA
 NM_009891 choline acetyltransferase (Chat), mRNA [NM_009891] KLA 1.03 1.02 1.01 1.05 1.03 .96 1.06
ATP .99 1.01 1.03 1.05 1.01 1.00 .99
KLA/ATP 1.02 1.01 1.00 .97 .98 .94 1.03
Chka
KLA  ATP  ATP+KLA
 AK014174 13 days embryo head cDNA, RIKEN full-length enriched library, clone:3110043M12 product:choline kinase, full insert sequence. [AK014174] KLA .42 .41 .44 .58 .89 .72 .81
ATP .83 .53 3.69 5.23 2.51 1.20 .99
KLA/ATP .37 .40 3.80 4.15 2.66 1.08 1.73
Chka
KLA  ATP  ATP+KLA
 NM_013490 choline kinase alpha (Chka), transcript variant 1, mRNA [NM_013490] KLA .62 .60 .67 .66 .85 .88 1.05
ATP 1.09 1.02 2.21 7.77 6.32 3.01 1.39
KLA/ATP .67 .65 1.77 6.85 7.26 3.77 2.70
Chkb
KLA  ATP  ATP+KLA
 NM_007692 choline kinase beta (Chkb), mRNA [NM_007692] KLA .71 .73 .70 .66 .86 .79 .78
ATP .97 .86 .73 .87 1.36 1.43 .96
KLA/ATP .68 .55 .52 .62 1.24 1.30 1.11
Chpt1
KLA  ATP  ATP+KLA
 NM_144807 choline phosphotransferase 1 (Chpt1), mRNA [NM_144807] KLA 1.16 1.18 1.24 1.15 1.16 1.10 1.23
ATP 1.01 1.05 1.16 1.09 .99 .97 .98
KLA/ATP 1.20 1.15 1.13 1.18 1.17 1.33 1.25
Crls1
KLA  ATP  ATP+KLA
 AK078599 11 days embryo gonad cDNA, RIKEN full-length enriched library, clone:7030418E13 product:unclassifiable, full insert sequence [AK078599] KLA .82 .86 .79 .88 .81 .89 .89
ATP .92 .91 1.00 .98 .87 .90 .68
KLA/ATP .77 .84 .81 .83 .80 .84 .58
Crls1
KLA  ATP  ATP+KLA
 NM_001024385 cardiolipin synthase 1 (Crls1), transcript variant 1, mRNA [NM_001024385] KLA .95 .98 .88 .88 .83 .67 1.02
ATP 1.13 1.14 .96 1.08 1.26 1.02 .86
KLA/ATP .98 .98 .83 .81 .73 .74 .77
D5Wsu178
e
KLA  ATP  ATP+KLA
 NM_027652 DNA segment, Chr 5, Wayne State University 178, expressed (D5Wsu178e), mRNA [NM_027652] KLA .78 .80 .72 .75 .69 .70 .96
ATP 1.03 1.09 1.13 1.04 1.22 1.10 .91
KLA/ATP .78 .82 .72 .80 .96 .87 .73
Dgka
KLA  ATP  ATP+KLA
 NM_016811 diacylglycerol kinase, alpha (Dgka), mRNA [NM_016811] KLA 3.34 3.15 3.23 3.20 2.95 1.29 .45
ATP 1.11 .97 1.01 .90 1.32 1.39 1.33
KLA/ATP 2.97 3.42 3.95 2.85 2.49 1.47 1.21
Dgkb
KLA  ATP  ATP+KLA
 AK032509 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430574F24 product:DIACYLGLYCEROL KINASE, BETA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK- BETA) (DAG KINASE BETA) (90 KDA DIACYLGLYCEROL KINASE) homolog [Rattus nor KLA .92 .92 .98 .93 1.01 1.06 1.00
ATP 1.03 1.05 .97 1.00 .95 1.03 .99
KLA/ATP 1.00 1.07 1.02 .97 1.00 .96 .97
Dgkb
KLA  ATP  ATP+KLA
 AK083222 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630029D13 product:DIACYLGLYCEROL KINASE, BETA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK- BETA) (DAG KINASE BETA) (90 KDA DIACYLGLYCEROL KINASE) homolog [Rattus norvegi KLA 1.02 1.02 1.12 1.01 1.00 1.05 .99
ATP .97 1.01 1.06 .95 1.07 1.03 1.03
KLA/ATP .95 .99 1.05 1.02 1.04 .96 1.06
Dgkb
KLA  ATP  ATP+KLA
 AK122355 mRNA for mKIAA0718 protein [AK122355] KLA 1.03 .96 1.11 1.02 .95 .94 .97
ATP 1.00 .99 1.09 1.01 1.02 .96 .95
KLA/ATP .97 1.00 1.05 1.03 .95 1.02 .95
Dgkb
KLA  ATP  ATP+KLA
 NM_178681 diacylglycerol kinase, beta (Dgkb), mRNA [NM_178681] KLA 1.05 1.08 1.03 1.04 .94 1.01 1.04
ATP 1.04 1.02 1.04 .95 1.01 1.03 1.05
KLA/ATP 1.09 .95 1.00 1.03 1.06 1.05 1.05
Dgkd
KLA  ATP  ATP+KLA
 AK076439 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4832425N18 product:DIACYLGLYCEROL KINASE, DELTA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK-DELTA) (DAG KINASE DELTA) (130 KDA DIACYLGLYCEROL KINASE) (FRAGMENT) homolog [Homo KLA .43 .42 .38 .38 .44 .36 .28
ATP 1.08 1.06 .96 1.28 1.01 .42 .25
KLA/ATP .42 .41 .38 .39 .46 .40 .23
Dgkd
KLA  ATP  ATP+KLA
 AK172901 mRNA for mKIAA0145 protein [AK172901] KLA .27 .25 .22 .22 .23 .23 .22
ATP .87 .79 .81 .66 .58 .34 .31
KLA/ATP .22 .22 .19 .15 .20 .22 .15
Dgke
KLA  ATP  ATP+KLA
 NM_019505 diacylglycerol kinase, epsilon (Dgke), mRNA [NM_019505] KLA 1.17 1.16 1.09 .92 .86 .99 1.25
ATP 1.02 1.01 .92 .79 .99 1.14 1.10
KLA/ATP 1.19 1.16 .98 .87 .97 1.05 .88
Dgkg
KLA  ATP  ATP+KLA
 AK089261 NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630107L03 product:SIMILAR TO DIACYLGLYCEROL KINASE 3 (GAMMA) homolog [Mus musculus], full insert sequence. [AK089261] KLA .95 .91 .97 .98 .97 .93 .96
ATP 1.04 1.02 .96 .93 .98 .89 .88
KLA/ATP 1.02 .99 .92 .86 .95 .92 .90
Dgkg
KLA  ATP  ATP+KLA
 NM_138650 diacylglycerol kinase, gamma (Dgkg), mRNA [NM_138650] KLA .65 .64 .62 .78 .86 .68 .53
ATP .92 .99 1.04 .83 .67 .71 .55
KLA/ATP .60 .66 .66 .65 .84 1.00 .59
Dgkh
KLA  ATP  ATP+KLA
 AK031069 13 days embryo forelimb cDNA, RIKEN full-length enriched library, clone:5930402B05 product:DIACYLGLYCEROL KINASE, DELTA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK- DELTA) (DAG KINASE DELTA) (130 KDA DIACYLGLYCEROL KINASE) (DIACYLGLYCEROL KI KLA 3.02 2.91 2.42 2.25 1.93 1.46 1.40
ATP 1.04 1.08 1.10 1.28 1.46 1.35 .98
KLA/ATP 3.66 4.04 3.53 1.88 1.69 1.34 1.47
Dgkh
KLA  ATP  ATP+KLA
 NM_001081336 diacylglycerol kinase, eta (Dgkh), mRNA [NM_001081336] KLA 6.71 7.34 7.44 7.69 6.90 4.13 3.15
ATP .98 .96 1.02 1.20 2.01 3.95 2.09
KLA/ATP 6.79 7.17 6.53 7.03 4.73 5.21 5.62
Dgki
KLA  ATP  ATP+KLA
 AK086550 15 days embryo head cDNA, RIKEN full-length enriched library, clone:D930036J18 product:DIACYLGLYCEROL KINASE, IOTA (EC 2.7.1.107) (DIGLYCERIDE KINASE) (DGK- IOTA) (DAG KINASE IOTA) homolog [Homo sapiens], full insert sequence. [AK086550] KLA 1.03 1.00 .96 1.07 1.00 1.08 .95
ATP 1.06 .99 1.02 .96 .98 1.02 1.03
KLA/ATP .99 .99 .99 .97 .99 .92 .99
Dgki
KLA  ATP  ATP+KLA
 NM_001081206 diacylglycerol kinase, iota (Dgki), mRNA [NM_001081206] KLA .99 .96 .89 .99 .92 .98 1.02
ATP 1.00 1.01 .95 1.00 .95 .90 1.02
KLA/ATP .91 .86 1.02 .99 1.02 .90 .98
Dgkq
KLA  ATP  ATP+KLA
 NM_199011 diacylglycerol kinase, theta (Dgkq), mRNA [NM_199011] KLA 1.09 .95 1.05 .98 .93 .96 1.11
ATP .99 .78 .66 .44 .99 1.04 1.23
KLA/ATP .98 .73 .66 .47 .67 .89 1.15
Dgkz
KLA  ATP  ATP+KLA
 NM_138306 diacylglycerol kinase zeta (Dgkz), mRNA [NM_138306] KLA .21 .22 .23 .29 .56 1.23 1.39
ATP 1.08 1.25 .90 1.22 .85 .57 1.44
KLA/ATP .23 .22 .18 .31 .60 .80 1.45
Etnk1
KLA  ATP  ATP+KLA
 XM_908334 gb|PREDICTED: Mus musculus ethanolamine kinase 1 (Etnk1), mRNA [XM_908334] KLA 5.38 5.56 5.81 5.53 4.73 4.65 2.51
ATP 1.01 1.05 1.13 1.21 1.24 2.34 2.30
KLA/ATP 5.41 5.64 5.14 6.04 5.38 4.90 5.42
Etnk2
KLA  ATP  ATP+KLA
 NM_175443 ethanolamine kinase 2 (Etnk2), mRNA [NM_175443] KLA 3.96 3.87 3.49 2.74 1.76 1.22 1.04
ATP 1.03 1.09 1.14 1.15 1.11 1.20 1.10
KLA/ATP 3.78 3.98 3.07 2.56 1.95 1.49 1.15
Gnpat
KLA  ATP  ATP+KLA
 NM_010322 glyceronephosphate O-acyltransferase (Gnpat), mRNA [NM_010322] KLA .59 .61 .51 .42 .38 .45 .79
ATP .91 .88 .81 .66 .64 .39 .63
KLA/ATP .61 .54 .46 .38 .36 .34 .36
Gpam
KLA  ATP  ATP+KLA
 NM_008149 glycerol-3-phosphate acyltransferase, mitochondrial (Gpam), nuclear gene encoding mitochondrial protein, mRNA [NM_008149] KLA 1.04 .97 1.00 1.04 .90 .96 1.00
ATP .98 1.18 1.10 .95 .70 .98 1.37
KLA/ATP 1.03 1.06 1.05 1.01 .79 .89 1.00
Gpd1
KLA  ATP  ATP+KLA
 NM_010271 glycerol-3-phosphate dehydrogenase 1 (soluble) (Gpd1), mRNA [NM_010271] KLA .79 .84 .77 .78 .74 .78 .86
ATP 1.05 1.05 1.34 1.37 1.78 1.42 1.05
KLA/ATP .88 .84 .89 .92 2.08 1.48 1.11
Gpd1l
KLA  ATP  ATP+KLA
 AK172886 mRNA for mKIAA0089 protein [AK172886] KLA .58 .57 .61 .51 .46 .37 .56
ATP 1.16 1.26 .95 1.23 .77 .47 .77
KLA/ATP .67 .74 .43 .56 .39 .35 .27
Gpd1l
KLA  ATP  ATP+KLA
 NM_175380 glycerol-3-phosphate dehydrogenase 1-like (Gpd1l), mRNA [NM_175380] KLA 1.00 1.03 1.01 1.09 .92 .88 1.00
ATP .94 1.00 1.20 1.30 1.08 1.41 2.89
KLA/ATP 1.03 1.08 1.16 1.21 .99 .99 1.43
Gpd2
KLA  ATP  ATP+KLA
 AK080240 adult male aorta and vein cDNA, RIKEN full-length enriched library, clone:A530087K12 product:unclassifiable, full insert sequence [AK080240] KLA 6.19 5.66 6.35 7.05 6.91 5.10 4.29
ATP 1.09 1.20 1.18 1.45 1.74 2.10 .82
KLA/ATP 6.39 6.16 6.40 6.27 3.79 3.27 1.80
Gpd2
KLA  ATP  ATP+KLA
 NM_010274 glycerol phosphate dehydrogenase 2, mitochondrial (Gpd2), nuclear gene encoding mitochondrial protein, mRNA [NM_010274] KLA 7.02 7.38 7.93 8.16 9.15 6.88 5.03
ATP 1.15 1.18 1.17 1.50 1.72 2.76 1.41
KLA/ATP 7.76 7.40 7.37 7.82 5.17 4.95 4.49
Hrasls3
KLA  ATP  ATP+KLA
 AK052657 0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630015C01 product:H-REV 107 PROTEIN homolog [Rattus norvegicus], full insert sequence. [AK052657] KLA 4.07 4.01 2.57 2.26 1.94 1.66 1.10
ATP .93 .92 1.00 .96 .95 .99 1.08
KLA/ATP 3.36 2.63 1.76 1.26 1.41 1.22 1.27
Hrasls3
KLA  ATP  ATP+KLA
 NM_139269 HRAS like suppressor 3 (Hrasls3), mRNA [NM_139269] KLA 11.37 10.85 12.50 16.13 13.98 17.12 6.64
ATP .86 .78 .96 .89 .84 .99 1.03
KLA/ATP 8.90 10.50 15.81 13.10 11.95 11.16 10.19
LOC10004
4148
KLA  ATP  ATP+KLA
 XM_001471861 ref|PREDICTED: Mus musculus hypothetical protein LOC100044148 (LOC100044148), mRNA [XM_001471861] KLA 1.51 1.56 1.48 1.55 1.62 1.57 1.54
ATP 1.06 .97 1.08 .99 .93 1.35 1.36
KLA/ATP 1.54 1.49 1.70 1.46 1.47 1.47 1.60
Lcat
KLA  ATP  ATP+KLA
 NM_008490 lecithin cholesterol acyltransferase (Lcat), mRNA [NM_008490] KLA 1.23 1.14 1.21 1.16 1.18 1.03 1.03
ATP 1.11 1.18 1.24 1.59 1.43 1.18 .94
KLA/ATP 1.31 1.39 1.18 1.43 1.33 .97 .94
Lpcat1
KLA  ATP  ATP+KLA
 AK155286 NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630214O14 product:Hypothetical phospholipid and glycerol acyltransferase, full insert sequence [AK155286] KLA .94 .83 1.02 .83 1.42 .92 .90
ATP 1.33 1.28 1.03 .82 1.24 .58 .81
KLA/ATP 1.16 1.13 .83 .60 .71 .53 .50
Lpcat2
KLA  ATP  ATP+KLA
 NM_173014 lysophosphatidylcholine acyltransferase 2 (Lpcat2), mRNA [NM_173014] KLA 1.61 1.75 1.91 2.26 3.20 3.80 3.31
ATP 1.06 1.08 1.21 1.23 1.11 1.94 1.31
KLA/ATP 1.61 1.55 1.72 1.65 1.14 1.27 2.62
Lpgat1
KLA  ATP  ATP+KLA
 AK172914 mRNA for mKIAA0205 protein [AK172914] KLA .54 .47 .40 .38 .34 .44 .56
ATP .85 .86 1.07 .79 .89 .77 .91
KLA/ATP .44 .46 .57 .42 .60 .46 .34
Lpgat1
KLA  ATP  ATP+KLA
 NM_172266 lysophosphatidylglycerol acyltransferase 1 (Lpgat1), mRNA [NM_172266] KLA .75 .78 .66 .67 .59 .63 .88
ATP 1.01 1.02 1.07 .95 1.06 1.71 2.69
KLA/ATP .79 .76 .77 .71 .82 .96 2.07
Lpin1
KLA  ATP  ATP+KLA
 AF180471 Lpin1 (Kiaa0188) mRNA, complete cds [AF180471] KLA .26 .24 .29 .31 .26 .25 .24
ATP 1.23 .96 1.11 .97 .82 .43 .62
KLA/ATP .27 .25 .42 .37 .49 .34 .22
Lpin1
KLA  ATP  ATP+KLA
 NM_015763 lipin 1 (Lpin1), transcript variant 2, mRNA [NM_015763] KLA .19 .19 .18 .20 .18 .16 .19
ATP 1.02 .99 1.06 .93 .70 .35 .70
KLA/ATP .18 .17 .27 .25 .30 .25 .16
Lpin3
KLA  ATP  ATP+KLA
 NM_022883 lipin 3 (Lpin3), mRNA [NM_022883] KLA .99 .98 1.06 1.04 1.01 .99 .99
ATP 1.03 1.01 1.02 .92 1.00 1.03 .91
KLA/ATP 1.03 .97 .99 .99 .92 .91 1.02
Lycat
KLA  ATP  ATP+KLA
 NM_001081071 lysocardiolipin acyltransferase (Lycat), mRNA [NM_001081071] KLA 1.03 .96 1.02 .97 1.02 .94 .99
ATP 1.09 1.08 .99 .94 .75 .90 1.06
KLA/ATP 1.02 1.10 .98 .91 .73 .97 1.03
Lypla1
KLA  ATP  ATP+KLA
 NM_008866 lysophospholipase 1 (Lypla1), mRNA [NM_008866] KLA 1.52 1.63 1.61 1.63 1.48 1.33 1.38
ATP 1.03 1.17 1.34 1.45 .98 .79 1.34
KLA/ATP 1.36 1.53 1.56 1.79 1.11 .90 1.39
Lypla2
KLA  ATP  ATP+KLA
 NM_011942 lysophospholipase 2 (Lypla2), mRNA [NM_011942] KLA .88 .87 .77 .82 .79 .98 1.10
ATP 1.00 .96 1.11 .99 .82 .91 1.20
KLA/ATP .83 .86 .84 .81 .84 .92 1.25
Lypla3
KLA  ATP  ATP+KLA
 NM_133792 lysophospholipase 3 (Lypla3), mRNA [NM_133792] KLA .39 .40 .37 .35 .43 .61 .79
ATP 1.16 1.25 1.07 1.55 2.07 1.18 .64
KLA/ATP .48 .44 .38 .71 1.44 1.29 .47
Mboat1
KLA  ATP  ATP+KLA
 NM_153546 membrane bound O-acyltransferase domain containing 1 (Mboat1), mRNA [NM_153546] KLA .55 .57 .44 .39 .23 .14 .12
ATP .86 .94 1.05 1.04 .90 .52 .14
KLA/ATP .53 .53 .55 .53 .46 .35 .12
Mboat2
KLA  ATP  ATP+KLA
 AK031682 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030487B18 product:unclassifiable, full insert sequence [AK031682] KLA .94 .98 .99 .97 .92 1.08 1.08
ATP 1.00 .99 1.05 1.01 1.03 1.01 1.07
KLA/ATP 1.02 1.06 .99 1.06 1.08 1.14 .96
Mboat2
KLA  ATP  ATP+KLA
 NM_026037 membrane bound O-acyltransferase domain containing 2 (Mboat2), transcript variant 1, mRNA [NM_026037] KLA .84 .87 .81 .81 .81 .83 .95
ATP 1.03 1.01 1.04 1.01 1.10 1.02 .88
KLA/ATP .89 .88 .98 .91 .89 1.01 1.11
Mboat5
KLA  ATP  ATP+KLA
 NM_145130 membrane bound O-acyltransferase domain containing 5 (Mboat5), mRNA [NM_145130] KLA .93 .94 1.07 .90 .97 .94 1.01
ATP 1.13 1.10 1.02 1.02 .90 .76 1.30
KLA/ATP 1.15 1.03 .85 .97 .68 .73 1.08
Mboat7
KLA  ATP  ATP+KLA
 AK134975 adult male olfactory brain cDNA, RIKEN full-length enriched library, clone:6430532G23 product:hypothetical protein, full insert sequence. [AK134975] KLA .95 .92 1.00 .95 1.04 1.00 1.01
ATP .92 1.00 1.00 .93 1.09 .96 .99
KLA/ATP .89 .93 1.03 .93 1.02 .98 .91
Mboat7
KLA  ATP  ATP+KLA
 NM_029934 membrane bound O-acyltransferase domain containing 7 (Mboat7), mRNA [NM_029934] KLA 1.01 .99 1.12 1.12 1.24 1.02 1.05
ATP 1.19 1.15 .96 1.18 1.24 1.34 1.52
KLA/ATP 1.12 1.16 .93 1.22 .90 1.10 1.71
Mm.16006
7
KLA  ATP  ATP+KLA
 124487226 Unknown KLA .90 .88 .87 .85 .80 .85 .64
ATP .95 .95 1.00 .94 1.00 .91 .67
KLA/ATP .89 .86 .93 .82 .85 .84 .63
Mm.22792
4
KLA  ATP  ATP+KLA
 142373198 Unknown KLA 1.61 1.61 1.22 1.43 1.87 1.90 1.75
ATP 1.08 1.06 1.09 2.61 2.93 1.89 2.18
KLA/ATP 1.40 1.68 1.35 1.68 1.51 1.39 2.31
Mm.24244
KLA  ATP  ATP+KLA
 23956161 Unknown KLA 1.04 1.00 .96 1.04 1.53 1.13 1.09
ATP 1.17 1.30 .97 1.10 1.09 1.26 1.10
KLA/ATP .92 1.07 .82 .97 .80 .96 .74
Mm.28873
KLA  ATP  ATP+KLA
 110431340 Unknown KLA .79 .72 .69 .71 .44 .32 .37
ATP .89 .88 1.17 .98 1.11 .98 .73
KLA/ATP .67 .72 .87 .74 .75 .53 .30
Mm.32919
4
KLA  ATP  ATP+KLA
 124486721 Unknown KLA 1.02 .91 .92 .99 .85 .96 .84
ATP .97 .92 1.29 .82 .56 1.00 .95
KLA/ATP .90 .98 1.13 .79 .71 1.06 .84
Mm.33050
7
KLA  ATP  ATP+KLA
 67906182 Unknown KLA .94 .98 .99 1.03 1.05 1.07 .98
ATP .95 1.02 .97 .98 .99 1.05 1.02
KLA/ATP 1.02 1.05 1.01 1.03 .99 .98 .97
Mm.33438
KLA  ATP  ATP+KLA
 46402174 Unknown KLA 1.14 1.18 1.15 .97 .93 .89 .84
ATP 1.02 1.20 2.15 1.34 .98 .89 .86
KLA/ATP 1.23 1.19 .91 1.16 .78 .90 .86
Mm.34302
KLA  ATP  ATP+KLA
 7242155 Unknown KLA .91 .82 .82 .82 .81 .90 1.02
ATP 1.01 .95 1.09 .93 .85 .90 1.08
KLA/ATP .70 .79 .89 .81 .76 .79 1.10
Mm.41173
7
KLA  ATP  ATP+KLA
 124486740 Unknown KLA 6.95 6.26 6.49 5.66 6.34 2.93 3.01
ATP 1.18 1.40 1.03 1.27 1.96 1.87 1.53
KLA/ATP 6.62 7.00 6.07 6.81 2.75 2.22 2.84
Mm.44250
5
KLA  ATP  ATP+KLA
 124487070 Unknown KLA .93 .96 1.03 1.01 .97 .93 1.17
ATP 1.04 .91 .96 .96 .99 .89 .96
KLA/ATP .95 .89 .70 1.01 .95 1.00 .96
Mm.71913
KLA  ATP  ATP+KLA
 118130231 Unknown KLA .93 1.00 1.06 .97 .95 .98 1.04
ATP 1.00 .98 1.08 1.02 .92 .90 .99
KLA/ATP .99 1.01 1.00 .99 .99 .99 1.01
Pcyt1a
KLA  ATP  ATP+KLA
 AK163685 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930020C23 product:phosphate cytidylyltransferase 1, choline, alpha isoform, full insert sequence [AK163685] KLA .63 .65 .76 .82 .87 1.04 .67
ATP 1.00 1.10 .81 1.07 2.85 1.72 1.60
KLA/ATP .64 .63 .48 .97 2.62 2.63 1.66
Pcyt1a
KLA  ATP  ATP+KLA
 NM_009981 phosphate cytidylyltransferase 1, choline, alpha isoform (Pcyt1a), mRNA [NM_009981] KLA .67 .77 .90 .96 .99 1.16 .81
ATP .93 1.04 .85 1.22 2.93 1.57 1.91
KLA/ATP .72 .73 .82 1.17 2.79 2.47 1.62
Pcyt1b
KLA  ATP  ATP+KLA
 NM_211138 phosphate cytidylyltransferase 1, choline, beta isoform (Pcyt1b), transcript variant 1, mRNA [NM_211138] KLA .91 .84 .85 .88 .85 .79 .65
ATP 1.04 1.05 .96 .91 .82 .81 .68
KLA/ATP .86 .84 .87 .87 .82 .78 .59
Pcyt2
KLA  ATP  ATP+KLA
 NM_024229 phosphate cytidylyltransferase 2, ethanolamine (Pcyt2), mRNA [NM_024229] KLA .58 .57 .56 .46 .50 .42 .54
ATP .98 .94 1.04 .99 .71 .66 1.11
KLA/ATP .59 .59 .60 .54 .43 .35 .45
Pemt
KLA  ATP  ATP+KLA
 NM_008819 phosphatidylethanolamine N-methyltransferase (Pemt), nuclear gene encoding mitochondrial protein, mRNA [NM_008819] KLA 1.00 1.08 1.08 .99 .92 .83 .93
ATP 1.08 1.16 1.04 1.22 1.02 .89 .84
KLA/ATP 1.14 1.10 .92 1.05 .83 .76 .71
Pgs1
KLA  ATP  ATP+KLA
 NM_133757 phosphatidylglycerophosphate synthase 1 (Pgs1), mRNA [NM_133757] KLA 2.65 2.70 2.52 2.72 2.54 2.28 1.89
ATP .97 .98 1.06 1.17 1.57 2.20 1.91
KLA/ATP 2.60 2.62 2.92 2.95 2.95 2.64 2.37
Phospho1
KLA  ATP  ATP+KLA
 NM_153104 phosphatase, orphan 1 (Phospho1), mRNA [NM_153104] KLA .99 1.04 1.04 1.14 1.01 1.15 1.21
ATP .95 1.01 .99 1.05 1.11 1.22 1.42
KLA/ATP 1.04 1.02 1.05 1.11 1.01 1.45 1.40
Pisd
KLA  ATP  ATP+KLA
 NM_177298 phosphatidylserine decarboxylase (Pisd), mRNA [NM_177298] KLA .71 .66 .72 .80 .95 .98 1.03
ATP 1.00 .89 .79 .67 .96 1.16 .99
KLA/ATP .69 .65 .58 .58 .90 1.12 .99
Pla2g10
KLA  ATP  ATP+KLA
 NM_011987 phospholipase A2, group X (Pla2g10), mRNA [NM_011987] KLA .99 1.11 1.02 .99 1.00 1.01 1.02
ATP 1.02 .97 1.01 1.03 1.00 1.02 1.04
KLA/ATP 1.04 .96 .95 1.04 1.06 1.05 1.01
Pla2g12a
KLA  ATP  ATP+KLA
 NM_023196 phospholipase A2, group XIIA (Pla2g12a), transcript variant 1, mRNA [NM_023196] KLA 1.03 1.06 .97 1.00 .78 .75 .92
ATP .91 .99 1.29 1.30 1.20 1.48 1.71
KLA/ATP .92 .99 1.19 1.16 1.06 1.12 1.36
Pla2g12a
KLA  ATP  ATP+KLA
 NM_183423 phospholipase A2, group XIIA (Pla2g12a), transcript variant 2, mRNA [NM_183423] KLA .90 1.00 .87 .95 .76 .68 .88
ATP .96 .94 1.26 1.24 1.19 1.47 1.88
KLA/ATP .89 .90 1.08 1.07 1.06 1.02 1.59
Pla2g12b
KLA  ATP  ATP+KLA
 NM_023530 phospholipase A2, group XIIB (Pla2g12b), mRNA [NM_023530] KLA .98 .95 1.05 .99 1.03 .99 .94
ATP 1.02 1.04 1.07 1.05 .92 1.04 1.00
KLA/ATP .98 .92 1.10 1.11 1.09 1.03 1.04
Pla2g1b
KLA  ATP  ATP+KLA
 NM_011107 phospholipase A2, group IB, pancreas (Pla2g1b), mRNA [NM_011107] KLA 1.00 1.01 1.01 1.11 1.00 1.28 1.00
ATP .98 1.03 1.09 1.03 1.01 1.02 1.04
KLA/ATP .93 .94 1.01 1.00 .94 1.09 1.07
Pla2g2a
KLA  ATP  ATP+KLA
 NM_001082531 phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), mRNA [NM_001082531] KLA 1.08 .99 1.00 1.06 .98 1.01 .94
ATP 1.07 .98 1.04 1.06 .90 .98 .98
KLA/ATP .98 1.03 1.00 1.04 .94 .97 .96
Pla2g2c
KLA  ATP  ATP+KLA
 NM_008868 phospholipase A2, group IIC (Pla2g2c), mRNA [NM_008868] KLA .98 .99 1.05 .98 1.01 1.00 1.04
ATP 1.08 1.06 1.09 .93 .92 .92 1.00
KLA/ATP 1.03 1.04 1.02 1.04 .98 1.01 1.02
Pla2g2d
KLA  ATP  ATP+KLA
 NM_011109 phospholipase A2, group IID (Pla2g2d), mRNA [NM_011109] KLA 1.02 1.02 .99 .99 1.00 1.01 1.00
ATP .95 1.11 1.10 1.11 .98 .99 1.12
KLA/ATP 1.02 1.00 1.19 1.11 1.00 .96 1.01
Pla2g2e
KLA  ATP  ATP+KLA
 NM_012044 phospholipase A2, group IIE (Pla2g2e), mRNA [NM_012044] KLA .78 .75 .74 .72 .62 .69 1.40
ATP 1.06 1.00 .92 1.04 .83 .76 3.74
KLA/ATP .78 .80 .69 .74 .70 .74 2.24
Pla2g2f
KLA  ATP  ATP+KLA
 NM_012045 phospholipase A2, group IIF (Pla2g2f), mRNA [NM_012045] KLA 1.02 .99 1.03 1.01 1.00 .95 .99
ATP 1.01 1.06 1.11 .97 1.09 1.11 .99
KLA/ATP 1.10 1.05 1.04 .95 1.04 1.01 .96
Pla2g3
KLA  ATP  ATP+KLA
 NM_172791 phospholipase A2, group III (Pla2g3), mRNA [NM_172791] KLA 1.04 1.05 1.02 1.01 1.04 1.11 1.00
ATP .96 .97 1.10 .91 .99 .97 1.08
KLA/ATP 1.03 1.11 1.10 .98 .95 .98 1.07
Pla2g4a
KLA  ATP  ATP+KLA
 NM_008869 phospholipase A2, group IVA (cytosolic, calcium-dependent) (Pla2g4a), mRNA [NM_008869] KLA 3.93 4.49 4.86 6.40 6.44 3.10 1.68
ATP 1.13 1.36 1.27 1.30 1.02 5.37 1.47
KLA/ATP 3.64 4.45 4.76 7.11 2.96 4.08 2.60
Pla2g4b
KLA  ATP  ATP+KLA
 NM_145378 phospholipase A2, group IVB (cytosolic) (Pla2g4b), mRNA [NM_145378] KLA 1.09 1.18 .95 1.01 .97 .97 .77
ATP 1.05 1.14 1.28 .94 .88 1.18 .70
KLA/ATP 1.23 1.43 1.21 1.02 1.15 1.16 .78
Pla2g4c
KLA  ATP  ATP+KLA
 AK145339 1 cell embryo 1 cell cDNA, RIKEN full-length enriched library, clone:I0C0013F18 product:weakly similar to Cytosolic phospholipase A2 gamma [Homo sapiens], full insert sequence [AK145339] KLA 1.09 1.21 1.33 1.17 1.26 1.30 1.05
ATP .97 1.06 1.00 .98 .98 .98 1.05
KLA/ATP 1.19 1.16 1.18 1.13 1.04 1.02 1.06
Pla2g4c
KLA  ATP  ATP+KLA
 NM_001004762 phospholipase A2, group IVC (cytosolic, calcium-independent) (Pla2g4c), mRNA [NM_001004762] KLA .93 1.00 .94 .93 .94 .94 .96
ATP .98 .96 1.13 .97 .99 .89 .96
KLA/ATP 1.01 1.01 1.07 1.01 .94 1.01 .92
Pla2g4e
KLA  ATP  ATP+KLA
 AK049063 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230096D22 product:hypothetical Lysophospholipase catalytic domain containing protein, full insert sequence. [AK049063] KLA 1.03 1.09 1.01 1.01 1.06 .94 1.05
ATP 1.03 1.00 1.06 1.01 .96 1.05 1.05
KLA/ATP .98 1.00 1.01 .98 1.03 .95 1.01
Pla2g4e
KLA  ATP  ATP+KLA
 NM_177845 phospholipase A2, group IVE (Pla2g4e), mRNA [NM_177845] KLA .97 .95 1.01 .97 1.02 1.03 1.05
ATP .98 .99 1.00 1.10 .98 1.00 1.02
KLA/ATP 1.05 .93 .96 1.03 1.08 1.05 .99
Pla2g4f
KLA  ATP  ATP+KLA
 NM_001024145 phospholipase A2, group IVF (Pla2g4f), mRNA [NM_001024145] KLA 1.08 .99 1.04 1.02 1.04 .98 1.01
ATP .99 1.04 .99 1.03 1.12 1.01 1.25
KLA/ATP .97 1.04 1.10 1.06 1.04 1.03 1.03
Pla2g5
KLA  ATP  ATP+KLA
 NM_011110 phospholipase A2, group V (Pla2g5), transcript variant 2, mRNA [NM_011110] KLA .65 .62 .56 .53 .62 1.60 3.01
ATP .90 .82 .88 1.69 1.82 1.26 6.32
KLA/ATP .63 .59 .65 .63 .91 1.56 5.59
Pla2g6
KLA  ATP  ATP+KLA
 NM_016915 phospholipase A2, group VI (Pla2g6), mRNA [NM_016915] KLA .60 .59 .56 .60 .94 1.31 1.59
ATP 1.10 1.14 .95 1.05 1.06 1.13 1.14
KLA/ATP .63 .56 .54 .56 .71 .97 1.55
Plb1
KLA  ATP  ATP+KLA
 AK015993 adult male testis cDNA, RIKEN full-length enriched library, clone:4930539A06 product:weakly similar to PHOSPHOLIPASE B [Rattus norvegicus], full insert sequence. [AK015993] KLA .99 .99 1.05 1.02 1.03 1.07 1.02
ATP 1.04 1.03 1.07 1.06 1.09 1.01 1.02
KLA/ATP 1.07 1.00 .96 1.09 1.05 1.08 1.01
Plb1
KLA  ATP  ATP+KLA
 AK087596 2 days pregnant adult female oviduct cDNA, RIKEN full-length enriched library, clone:E230021C09 product:hypothetical protein, full insert sequence. [AK087596] KLA .93 .99 .99 1.07 .98 1.00 .98
ATP 1.08 1.00 .97 1.07 1.04 1.09 .96
KLA/ATP 1.06 .96 1.00 .98 1.04 1.06 .98
Plb1
KLA  ATP  ATP+KLA
 NM_001081407 phospholipase B1 (Plb1), mRNA [NM_001081407] KLA 1.05 1.09 1.05 1.04 1.05 1.03 .85
ATP .96 1.03 1.02 .95 1.06 1.01 .92
KLA/ATP 1.00 1.00 1.09 1.00 .97 .99 .86
Pld1
KLA  ATP  ATP+KLA
 NM_008875 phospholipase D1 (Pld1), mRNA [NM_008875] KLA .71 .73 .67 .73 .88 .96 1.25
ATP .99 .88 .73 .68 .45 1.23 1.12
KLA/ATP .70 .67 .58 .59 .48 .91 1.48
Pld2
KLA  ATP  ATP+KLA
 NM_008876 phospholipase D2 (Pld2), mRNA [NM_008876] KLA .51 .54 .48 .51 .73 .79 1.02
ATP 1.06 1.10 .88 1.03 1.04 1.29 1.00
KLA/ATP .63 .52 .40 .57 .65 1.03 1.35
Pld3
KLA  ATP  ATP+KLA
 NM_011116 phospholipase D family, member 3 (Pld3), mRNA [NM_011116] KLA .81 .84 .90 .75 .75 .70 .82
ATP 1.06 1.14 .81 1.15 1.12 .97 1.32
KLA/ATP .94 .92 .73 1.01 .94 1.05 1.20
Pld4
KLA  ATP  ATP+KLA
 NM_178911 phospholipase D family, member 4 (Pld4), mRNA [NM_178911] KLA .66 .73 .82 .67 .90 1.14 1.94
ATP 1.08 1.24 .87 1.26 .86 .50 .75
KLA/ATP .84 .83 .51 .83 .56 .61 1.00
Pnpla6
KLA  ATP  ATP+KLA
 NM_015801 patatin-like phospholipase domain containing 6 (Pnpla6), transcript variant 2, mRNA [NM_015801] KLA .89 .87 .93 .81 .94 .84 1.24
ATP 1.18 1.24 .91 .90 .73 1.05 1.51
KLA/ATP .99 1.01 .75 .80 .72 1.02 1.39
Pnpla7
KLA  ATP  ATP+KLA
 NM_146251 patatin-like phospholipase domain containing 7 (Pnpla7), mRNA [NM_146251] KLA .63 .60 .59 .44 .39 .40 .65
ATP 1.05 1.02 .85 .87 .74 .36 .81
KLA/ATP .63 .63 .50 .54 .47 .40 .51
Ppap2a
KLA  ATP  ATP+KLA
 NM_008903 phosphatidic acid phosphatase 2a (Ppap2a), transcript variant 2, mRNA [NM_008903] KLA 2.62 2.86 4.01 5.61 7.84 10.88 16.35
ATP 1.01 1.02 1.09 1.28 1.27 2.38 1.44
KLA/ATP 2.78 2.78 2.99 3.43 2.85 3.59 6.59
Ppap2b
KLA  ATP  ATP+KLA
 NM_080555 phosphatidic acid phosphatase type 2B (Ppap2b), mRNA [NM_080555] KLA 2.73 2.72 2.65 2.39 1.07 1.48 3.26
ATP .99 .97 1.60 2.76 18.64 27.23 9.19
KLA/ATP 2.69 2.80 4.36 4.20 14.33 15.32 17.91
Ppap2c
KLA  ATP  ATP+KLA
 NM_015817 phosphatidic acid phosphatase type 2c (Ppap2c), mRNA [NM_015817] KLA .94 .88 .91 .79 .65 .46 .51
ATP 1.01 1.03 1.00 1.12 1.24 .90 .83
KLA/ATP .95 .93 .87 .95 .79 .63 .43
Ptdss1
KLA  ATP  ATP+KLA
 NM_008959 phosphatidylserine synthase 1 (Ptdss1), mRNA [NM_008959] KLA .88 .95 .96 .86 .88 .92 1.05
ATP 1.02 1.05 .90 1.08 .99 .93 1.17
KLA/ATP .95 .93 .81 .85 .67 .83 1.10
Ptdss2
KLA  ATP  ATP+KLA
 NM_013782 phosphatidylserine synthase 2 (Ptdss2), mRNA [NM_013782] KLA .95 .96 1.02 1.06 1.17 1.34 1.27
ATP .90 .93 .92 1.04 .83 .86 1.34
KLA/ATP .93 .96 .93 .90 .90 .96 1.42
Taz
KLA  ATP  ATP+KLA
 AK019872 11 days pregnant adult female ovary and uterus cDNA, RIKEN full-length enriched library, clone:5031411C02 product:hypothetical protein, full insert sequence [AK019872] KLA .81 .78 .72 .79 1.01 .85 1.06
ATP .89 .77 .54 .55 .80 .72 1.04
KLA/ATP .73 .66 .55 .66 .74 .74 1.09
Taz
KLA  ATP  ATP+KLA
 NM_181516 tafazzin (Taz), mRNA [NM_181516] KLA .75 .78 .81 .92 1.00 .87 1.16
ATP 1.04 .94 .74 .71 .51 .46 1.02
KLA/ATP .82 .78 .75 .68 .53 .48 .96